{
  "actions": [
    {
      "acted_at": "2017-11-29", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-11-29", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-11-29", 
      "action_code": "H11100", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2017-12-01", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2018-01-09", 
      "action_code": "", 
      "committees": [
        "HSJU"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4482-115", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU", 
      "subcommittee": "Subcommittee on Crime, Terrorism, and Homeland Security", 
      "subcommittee_id": "08"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "B001305", 
      "district": "13", 
      "name": "Budd, Ted", 
      "original_cosponsor": false, 
      "sponsored_at": "2018-01-11", 
      "state": "NC", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "R000586", 
      "district": "16", 
      "name": "Renacci, James B.", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-11-29", 
      "state": "OH", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-11-29", 
  "number": "4482", 
  "official_title": "To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr4408-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s892-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "hr5914-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Opioid Abuse Deterrence, Research, and Recovery Act of 2017", 
  "sponsor": {
    "bioguide_id": "M001187", 
    "district": "11", 
    "name": "Meadows, Mark", 
    "state": "NC", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-11-29", 
  "subjects": [
    "Administrative law and regulatory procedures", 
    "Congressional oversight", 
    "Crime and law enforcement", 
    "Drug therapy", 
    "Drug trafficking and controlled substances", 
    "Drug, alcohol, tobacco use", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health care coverage and access", 
    "Health information and medical records", 
    "Health personnel", 
    "Health programs administration and funding", 
    "Licensing and registrations", 
    "Prescription drugs", 
    "State and local government operations"
  ], 
  "subjects_top_term": "Crime and law enforcement", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2017-11-29T05:00:00Z", 
    "text": "Opioid Abuse Deterrence, Research, and Recovery Act of 2017\n\nThis bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II or III unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.\n\nCertain opioid prescriptions are not subject to the limit (e.g., an opioid that is approved and prescribed for the treatment of an opioid use disorder).\n\nThe Food and Drug Administration (FDA) must continue to work with stakeholders to promote the development of abuse-deterrent opioid formulations.\n\nThe bill requires: (1) the Government Accountability Office to study and report on health care policy changes that may have contributed to the increase in opioid overdoses and deaths, and (2) the FDA to study the feasibility of replacing opioid prescribing limits established by this bill with evidence-based clinical guidelines for opioid prescribing."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Abuse Deterrence, Research, and Recovery Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Opioid Abuse Deterrence, Research, and Recovery Act of 2017", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Opioid Abuse Deterrence, Research, and Recovery Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:18:27Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/hr/BILLSTATUS-115hr4482.xml"
}